Clinton to Propose Curbs on ‘Unjustified’ Drug Price Hikes

  • Candidate will call for drug-pricing consumer response team
  • Criticism of EpiPen price led to Mylan’s drop last week

Mylan Plans Half-Priced Generic Version of EpiPen

Democratic presidential candidate Hillary Clinton, acting on her pledge to curb what she has called outrageous drug costs, outlined a set of proposals to crack down on “unjustified” increases on prices for older treatments.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.